TRVI Trevi Therapeutics Inc

USD 4.27 +0.06 ( +1.43%)
Icon

Trevi Therapeutics Inc (TRVI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.27

+0.06 (+1.43%)

USD 0.36B

0.76M

USD 7.50(+75.64%)

N/A

Icon

TRVI

Trevi Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 4.27
+0.06 ( +1.43%)

Discussions

No discussions yet.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...